MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • MDS Virtual Congress 2020

    Anticholinergic Burden in Parkinson’s Disease Patients in India – A Hospital Based Study

    A. Saini, R. Rajan, R. Anandapadmanabhan, V. Venogopalan, A. Gupta, B. Verma, N. Choudhary, R. Bhatia, M. Singh, A. Srivastava, P. Srivastava (New Delhi, India)

    Objective: To determine the cumulative anticholinergic burden in Indian Parkinson’s disease (PD) patients and to correlate the same with cognitive impairment and gait disturbance. Background:…
  • MDS Virtual Congress 2020

    Effects of a next-generation neurotrophic compound in a toxin model of Parkinson’s disease

    T. Viljakainen, M. Saarma, M. Voutilainen (Helsinki, Finland)

    Objective: Investigate the effects of a peripherally administered novel neurotrophic compound, CMx01a, in 6-hydroxydopamine rat model of Parkinson’s disease. Background: Neurotrophic factors are promising drug…
  • MDS Virtual Congress 2020

    Brain 5-HT1 receptor binding in multiple system atrophy: A [18F]-MPPF PET study

    M. Meyer, I. Sibon, F. Lamarre, J. Asselineau, A. Foubert-Samier, J. Mazère, A. Delamarre, O. Rascol, A. Pavy-Le Traon, F. Tison, P. Fernandez, W. Meissner (Bordeaux, France)

    Objective: The primary objective was to compare brain 5-HT1a receptor binding between patients with multiple system atrophy (MSA) and healthy controls (HC). The secondary objectives…
  • MDS Virtual Congress 2020

    Glucocerebrosidase activity and atypical parkinsonism: a multi-centre exploratory study

    R. Alvarez Velasco, P. Giraldo, P. Irun, L. Vela Desojo, L. Lopez Manzanares, J.M Arbelo González, M. Eimil Ortiz, A. Rojo Sebastian, M. Mata Álvarez-Santullano, I. Martínez Torres, J. Garcia-Caldentey, M. Gómez Gutierrez, C. Estévez-Fraga, J.L López Sendón, G. García Ribas, J.C Martínez Castrillo, A. Alonso-Canovas (Madrid, Spain)

    Objective: We aimed to determine the frequency of Glucocerebrosidase (GBA) deficiency (subclinical Gaucher's Disease type 1, GD1) in patients with atypical parkinsonism (AP) with features…
  • MDS Virtual Congress 2020

    Key neuropathological features separating corticobasal degeneration from other related disorders

    S. Rezvanian, I. Litvan, D. Dickson (La Jolla, CA, USA)

    Objective: This study investigated the key neuropathological features that could separate corticobasal degeneration (CBD) from related parkinsonian disorders by using a decision tree algorithm. Background:…
  • MDS Virtual Congress 2020

    Staircase sign for Atypical and Secondary parkinsonism

    Y.S Oh, J.S Kim, D.Y Kwon, M.H Park, B.R Bloem (Seoul, Republic of Korea)

    Objective: The aim of this study was to investigate the difference in the preference of staircase climbing in PD and atypical/ secondary parkinsonism when they…
  • MDS Virtual Congress 2020

    Benign Infantile Tremor Syndrome (BITS): a new movement disorder

    M. Hull, M. Parnes (Houston, TX, USA)

    Objective: We present infants at our institution presented with action tremor with onset weeks to months later after birth and otherwise similar to neonatal jitteriness. Background: Several benign movement disorders in infancy have been described including…
  • MDS Virtual Congress 2020

    Simultaneous, levodopa-responsive Holmes’ tremor and hemiparkinsonism due to midbrain cavernous malformation

    A. Dessy, P. Drummond (New York, NY, USA)

    Objective: We report a case of concomitant Holmes’ tremor (HT) and hemiparkinsonism (HP) attributable to a single structural lesion with robust clinical response to levodopa.…
  • MDS Virtual Congress 2020

    A tailored and multifactorial fall prevention program for people with Parkinson’s disease: a feasibility study

    N. Allen, L. Clemson, C. Sherrington, S. Lewis, J. Close, S. Lord, S. Paul, S. Singh, C. Canning (Sydney, Australia)

    Objective: To determine the feasibility and acceptability of a fall prevention program for people with moderate to severe Parkinson’s disease (PD). Background: Evidence shows exercise…
  • MDS Virtual Congress 2020

    Managing Functional Movement Disorder in Outpatient Physical Therapy: A Case Report of Belly-Dancer Dyskinesia

    R. Hand, J. Snider, J. Utt (Richmond, VA, USA)

    Objective: Abdominal dyskinesia, often referenced as belly dancer syndrome, is a poorly understood clinical presentation involving involuntary, undulating movements of the abdomen.1 Few cases have…
  • « Previous Page
  • 1
  • …
  • 26
  • 27
  • 28
  • 29
  • 30
  • …
  • 149
  • Next Page »

Most Viewed Abstracts

  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • “Magic carpet for freezing of gait ” Evaluating a combination of patterned and pictographic visual cues.
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley